945 related articles for article (PubMed ID: 35123084)
1. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.
Chen JW; Vela MF; Peterson KA; Carlson DA
Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1414-1421.e3. PubMed ID: 37061897
[TBL] [Abstract][Full Text] [Related]
4. AGA Clinical Practice Update on Functional Heartburn: Expert Review.
Fass R; Zerbib F; Gyawali CP
Gastroenterology; 2020 Jun; 158(8):2286-2293. PubMed ID: 32017911
[TBL] [Abstract][Full Text] [Related]
5. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
6. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review.
Muthusamy VR; Wani S; Gyawali CP; Komanduri S;
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2696-2706.e1. PubMed ID: 35788412
[TBL] [Abstract][Full Text] [Related]
8. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal Reflux Disease: A Review.
Maret-Ouda J; Markar SR; Lagergren J
JAMA; 2020 Dec; 324(24):2536-2547. PubMed ID: 33351048
[TBL] [Abstract][Full Text] [Related]
10. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Targownik LE; Fisher DA; Saini SD
Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
[TBL] [Abstract][Full Text] [Related]
11. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.
Yadlapati R; Vaezi MF; Vela MF; Spechler SJ; Shaheen NJ; Richter J; Lacy BE; Katzka D; Katz PO; Kahrilas PJ; Gyawali PC; Gerson L; Fass R; Castell DO; Craft J; Hillman L; Pandolfino JE
Am J Gastroenterol; 2018 Jul; 113(7):980-986. PubMed ID: 29686276
[TBL] [Abstract][Full Text] [Related]
12. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.
Iwakiri K; Kinoshita Y; Habu Y; Oshima T; Manabe N; Fujiwara Y; Nagahara A; Kawamura O; Iwakiri R; Ozawa S; Ashida K; Ohara S; Kashiwagi H; Adachi K; Higuchi K; Miwa H; Fujimoto K; Kusano M; Hoshihara Y; Kawano T; Haruma K; Hongo M; Sugano K; Watanabe M; Shimosegawa T
J Gastroenterol; 2016 Aug; 51(8):751-67. PubMed ID: 27325300
[TBL] [Abstract][Full Text] [Related]
14. Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?
Vaezi MF; Katzka D; Zerbib F
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1018-1029. PubMed ID: 29427733
[TBL] [Abstract][Full Text] [Related]
15. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
Roorda AK; Marcus SN; Triadafilopoulos G
Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
[TBL] [Abstract][Full Text] [Related]
16. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
Triadafilopoulos G; Kamal A; Clarke JO
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
[TBL] [Abstract][Full Text] [Related]
18. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians.
Shaheen NJ; Weinberg DS; Denberg TD; Chou R; Qaseem A; Shekelle P;
Ann Intern Med; 2012 Dec; 157(11):808-16. PubMed ID: 23208168
[TBL] [Abstract][Full Text] [Related]
19. Refractory Gastroesophageal Reflux Disease: Diagnosis and Management.
Davis TA; Gyawali CP
J Neurogastroenterol Motil; 2024 Jan; 30(1):17-28. PubMed ID: 38173155
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
